Answers are grounded in this paper and cite their sources.
Of 61 patients taking procainamide for longer than one month, three (4.9%) were found to have systemic lupus erythematosus. Five other patients with the syndrome were referred to us because it was suspected they were developing systemic lupus. Difficulties in definition of the syndrome are outlined; three other patients might have been included. The relevance of both the clinical assessment and the laboratory investigations in screening patients taking procainamide is discussed.
No takes yet. Share an insight, caveat, or question.
Hope et al. (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: